Penny Stock Under Rs 2: Evexia Lifecare Ltd reports revenue of Rs 47.82 crore and net profit of Rs 1 crore in H1FY26

On Monday, shares of Evexia Lifecare surged 0.60 per cent to Rs 1.75 per share from its previous closing of Rs 1.74 per share. The stock is up by 6 per cent from its 52-week low of Rs 2.07 per share.

Evexia Lifecare Limited, established in 1990 and listed on the Bombay Stock Exchange in 1994, has transformed into a diversified business entity. Initially focused on healthcare and wellness products, the company strategically shifted its primary focus to the pharmaceutical industry in 2020, specialising in trading pharmaceutical chemicals and forging partnerships with companies in South India. Evexia's vision is to become a global leader in healthcare and pharmaceuticals by driving innovation and delivering high-quality solutions, with a mission to provide top-quality pharmaceutical products and healthcare solutions through strategic collaborations, technological advancements, and a strong commitment to customer well-being. Their services include pharma chemical trading, personalised healthcare solutions, plastic reprocessing, and diagnostic solutions.

According to the financials, this FMCG company has a market cap of over Rs 300 crore and reported positive numbers in its Quarterly Results (Q2FY26) and half-yearly results (H1FY26).

In its quarterly results, the company reported net sales of Rs 25.73 crore and net profit of Rs 0.37 crore in Q2FY26. Looking at its half-yearly results, the company reports revenue of Rs 47.82 crore and net profit of Rs 1 crore in H1FY26. Looking at its annual results, the net sales increased by 96 per cent to Rs 110.48 crore and net profit decreased by 33 per cent to Rs 0.93 crore in FY25 compared to FY24.

Disclaimer: The article is for informational purposes only and not investment advice.